PRELUDE CAPITAL MANAGEMENT, LLC - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 93 filers reported holding ARCUS BIOSCIENCES INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q4 2020$447,000
+139.0%
17,221
+127.9%
0.01%
+10.0%
Q2 2020$187,000
+61.2%
7,558
-9.9%
0.01%
+25.0%
Q1 2020$116,000
+582.4%
8,392
+281.8%
0.01%
+700.0%
Q2 2019$17,000
+325.0%
2,198
+632.7%
0.00%
Q2 2018$4,0003000.00%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q1 2020
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$50,877,00022.64%
Octagon Capital Advisors LP 2,489,974$78,584,00016.99%
Decheng Capital Management III (Cayman), LLC 869,790$27,451,0008.41%
BVF INC/IL 3,960,948$125,008,0005.00%
PFM Health Sciences, LP 3,431,010$108,283,0004.05%
EcoR1 Capital, LLC 3,265,101$103,047,0003.22%
Alphabet Inc. 2,563,441$80,902,0002.62%
Boxer Capital, LLC 1,432,200$45,200,0002.32%
SECTORAL ASSET MANAGEMENT INC 338,480$10,682,0001.90%
PARK CIRCLE Co 64,000$2,020,0001.68%
View complete list of ARCUS BIOSCIENCES INC shareholders